Special Interest Group in Vaccines


  1. To foster development and adoption of methods to improve the accurate and efficient collection of vaccine exposure information (e.g., 2D barcodes, vaccine generic names, vaccine doses and dates of delivery) for each vaccinee.  Lot identifiers, in particular, would allow verification of the exact vaccine product (type and manufacturer) as well as linkage to details of vaccine antigens, preservatives, and excipients).
  2. To foster development and sharing of new/existing methods for vaccine safety, effectiveness, usage, cost-benefit, risk-management/mitigation across the life cycle of vaccines from pre- to post-licensure, and from signal detection to hypothesis testing.
  3. To provide a forum for interaction with regulatory authorities and public health agencies to raise awareness and stimulate incorporation of vaccine specific and relevant aspects into regulations and regulatory templates.
  4. To assist low and middle-income countries with development of their data collection and technical expertise in vaccine pharmacoepidemiology.


The SIG strives to achieve these goals by offering a platform for interested ISPE members to plan educational activities for the ICPE pre-conference courses together with the education committee, shared national and international projects and grant proposals, and joined presentation in form of workshops, symposia or poster walks at annual ICPE meetings. Whenever possible, the VAX SIG will seek to maximize synergy with existing vaccine institutions and stakeholders.

Committee Leaders

Chair James Stark, PhD Worldwide Safety and Regulatory
New York, USA
Immediate Past-Chair Harry Seifert, MD, MSCE Clinical Safety Sciences GSK
Pennsylvania, USA
Past Chair Bob Chen, MD, MA Brighton Collaboration
Atlanta, USA
Vice Chair Wan-Ting Huang, MD Office of Preventive Medicine, Taiwan Centers for Disease Control, Taipei, Taiwan
Secretary Catherine Panozzo, PhD, MPH Department of Population Medicine
Harvard Pilgrim Health Care Institute/Harvard Medical School

Workgroup Leaders

Regulatory Guidance Mendel Haag, PhD Epidemiology
Amsterdam, Netherlands
Methodology Patricia Saddier, MD, PhD Pharmacoepidemiology Department
Merck Research Laboratories
Pennsylvania, USA
Education and Advocacy in Low and Middle Income Countries Andrea Sutherland, MD Merck
Rockville, Maryland, USA
Education and Advocacy in Low and Middle Income Countries Daniel Weibel, PhD Erasmus University Medical Center
Rotterdam, Netherland


Victoria Abbing
Syed Ahmad
Valentina Attanasi
Steven Bailey
Meghan Baker
Sonja Banga
Vincent Bauchau
Jorgen Bauwens
Alex Bica
Kaat Bollaerts
Didier Nzolo Boolene
Bob Brody
Anne Butler
Bing Cai
Rebecca Chandler
Bob Chen
Jing Chen
Catherine Cohet
Adam Cui
Caitlin Dodd
Jonathan Duffy
Katherine Duszynski
Emmanuelle Espie
Germano Ferreira
Bruce Fireman
Vera Frajzyngier
Lourdes Frau
Kristin Goddard
Joanne Gruber
Mendel Haag
Penina Haber
Francois Haguinet
Eelko Hak
Janet Hardy
Kui Huang
Wei-I Huang
Wan-Ting Huang
Kwan Hur
Judith Jones
Sun-Young Jung
Dan Kajungu
Alison Kawai
Alena Khromava
Nicky Klein
Sonali Kochhar
Martin Kuldorff
Tamar Lasky
Bradley Layton
Andreia Leite
Olivia Mahaux
Morgan Marks
Robert Maroko
Josiah Masuka
Mike McNeil
Sharareh Modaressi
Pedro Moro
Yvonne Ohadike
Catherine Panozzo
Piku Patnaik
Silvia Perez Vilar
Vitali Pool
Nicolas Praet
Patricia Saddier
Daphne Sawlwin
Harry Seifert
Vivek Shinde
Francois Simondon
James Stark
Miriam Sturkenboom
Andrea Sutherland
Charlotte Switzer
Kyrstie Thai
Lina Titievsky
Sylvie Tomczyk
Thomas Verstraeten
Daniel Weibel
Lisa Weiss
Yonas Weldeselassie
Heather Whitaker
Corinne Willame
Jerome Wilson
Bob Wise
Katherine Yih
Huifeng Yun
Qusseny Zerbo

Dates of Meetings

Occurs the first Wednesday of every month at 9:00 am EST (UTC/GMT -5 hours). Interested persons should email Catherine Panozzo:

Meeting Minutes